Skip to content

Foundation Knee Study - Retrospective

Post-Market Study of the Foundation Knee System

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00764894
Enrollment
200
Registered
2008-10-02
Start date
2007-10-31
Completion date
2011-02-28
Last updated
2011-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis Secondary to Other Diseases, Avascular Necrosis of the Femoral Condyles, Inflammatory Tissue Disorders, Osteoarthritis, Post-traumatic Arthritis

Brief summary

The purpose of this study is to evaluate the use and efficacy of the Encore Foundation Knee System in a group of 200 patients for whom data has already been collected.

Interventions

DEVICEFoundation Knee

Subjects with degenerative joint disease (DJD), osteoarthritis or rheumatoid arthritis who received a primary Foundation Knee replacement and is willing to participate in the study.

Sponsors

Encore Medical, L.P.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have knee joint disease related to one or more of the following * osteoarthritis * post-traumatic arthritis * inflammatory tissue disorders * arthritis secondary to other diseases * Avascular necrosis of the femoral condyles; * Skeletal maturity * Less than 70 on the Knee Society Score (rating score) * Sufficient bone stock, as judged by radiographs, to support primary knee implant * Sufficient collateral ligaments to support the device, as judged by physician during stability testing (varus/valgus and flexion/extension) and less than 45 degree varus/valgus deformity and/or 90 degree flexion contracture * Patient is likely to be available for evaluation for the duration of the study * Able and willing to sign the informed consent and follow study procedures * Patient is not pregnant * No infection present * No known materials sensitivity

Exclusion criteria

* Skeletal immaturity * Greater than or equal to 70 on preoperative Knee Society Score (Rating Score) * Post-patellectomy * Insufficient bone quality which may affect implant stability * Insufficient collateral ligaments, as judged by the physician. Greater than 45 degree varus/valgus deformity and/or 90 degree flexion contracture. * Neurological conditions that might hinder patient's ability to follow study procedures (i.e., any that restrict physical activities such as Parkinson's Disease, Multiple Sclerosis, previous stroke which affects lower extremity) * Mental conditions that may interfere with ability to give an informed consent or willingness to fulfill the study requirements (i.e., severe mental retardation such that the patient cannot understand the informed consent process, global dementia, prior strokes that interfere with the patient's cognitive abilities, senile dementia, and Alzheimer's Disease) * Prisoners * Conditions that place excessive demand on the implant (i.e. Charcot's joints, muscle deficiencies, refusal to modify postoperative physical activities, skeletal immaturity) * Patient is pregnant * Infection present * Materials sensitivity

Design outcomes

Primary

MeasureTime frame
The use and efficacy of the Encore Foundation Knee System2 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026